Soliris Side Effects
Generic name: eculizumab
Note: This document contains side effect information about eculizumab. Some of the dosage forms listed on this page may not apply to the brand name Soliris.
Some side effects of Soliris may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to eculizumab: intravenous solution
Seek emergency medical attention or call your doctor right away if you notice any of these symptoms of meningitis:
-
headache and fever with nausea or vomiting;
-
high fever (103 degrees or higher), body aches, flu symptoms;
-
confusion, increased sensitivity to light; or
-
stiffness in your neck or back.
With your medication you will receive a Patient Safety Card listing the symptoms of meningococcal infection. Carry this card with you at all times.
Get emergency medical help if you have any of these signs of an allergic reaction while taking eculizumab (the active ingredient contained in Soliris) hives; chest pain, difficult breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these side effects during or after your treatment with eculizumab:
-
pale or yellowed skin, dark colored urine, fever, confusion or weakness;
-
feeling light-headed or short of breath, rapid heart rate, trouble concentrating;
-
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
-
pain or burning when you urinate;
-
swelling, rapid weight gain, urinating less or not at all;
-
sudden numbness or weakness, especially on one side of the body;
-
sudden severe headache, problems with vision, speech, or balance;
-
chest pain, sudden cough, wheezing, rapid breathing, coughing up blood;
-
pain, swelling, warmth, or redness in one or both legs; or
-
increased blood pressure (severe headache, blurred vision, buzzing in your ears, shortness of breath).
Common side effects may include:
-
mild headache;
-
nausea, vomiting, diarrhea;
-
back pain; or
-
cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to eculizumab: intravenous solution
Immunologic
Immunologic side effects have included herpes simplex infections (up to 7%), influenza-like illness (up to 5%), and immunogenicity (antibodies to eculizumab (the active ingredient contained in Soliris) detected in up to 3% of patients). Postmarketing cases of serious or fatal meningococcal infections have also been reported.
Respiratory
Respiratory side effects have included upper respiratory tract infection (up to 35%), nasopharyngitis (up to 23%), cough ( up to 14%), pharyngolaryngeal pain (up to 14%), sinusitis (up to 7%), and low titers of antibodies to eculizumab (the active ingredient contained in Soliris) (up to 3%).
Musculoskeletal
Musculoskeletal side effects have included back pain (up to 19%), pain in extremity (up to 11%), arthralgia (up to 7%), and myalgia (up to 7%).
Gastrointestinal
Gastrointestinal side effects have included diarrhea (up to 32%), vomiting (up to 22%), nausea (up to 19%), abdominal pain (up to 11%), and constipation (up to 7%).
Hematologic
Hematologic side effects have included anemia (up to 24%), and leukopenia (up to 16%).
Cardiovascular
Cardiovascular side effects have included hypertension (up to 35%).
Nervous system
Nervous system side effects have included headache (up to 44%), vertigo (up to 11%), and dizziness (up to 5%).
General
General side effects have included fatigue (up to 12%), peripheral edema (up to 11%), and pyrexia (up to 11%).
Psychiatric
Psychiatric side effects have included insomnia (up to 14%).
Genitourinary
Genitourinary side effects have included urinary tract infection (up to 16%).
More Soliris resources
- Soliris Prescribing Information (FDA)
- Soliris Monograph (AHFS DI)
- Soliris Advanced Consumer (Micromedex) - Includes Dosage Information
- Soliris Consumer Overview
- Soliris MedFacts Consumer Leaflet (Wolters Kluwer)
- Eculizumab Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


